click below
click below
Normal Size Small Size show me how
Viruses and Bacteria
| Term | Definition |
|---|---|
| N gonorrhoeae Organism structure morphology | Gram negative diplococci, oxidase +, catalase +, Glucose fermentation |
| N gonorrhoeae Epidemiology | C5-9 deficiencies at high risk, sexual contact STD |
| N gonorrhoeae Pathogenesis & Virulence Factors | Pili for non-ciliated epithelium, no capsule, IgA protease, antigenic changes in pili + OMPs, LOS and tissue damage, |
| N gonorrhoeae Clinical Disease STD | (purulent discharge) to cause cervicitis, salpingitis, ovaritis, urethritis, PID, Fitz-Hugh-Curtis syndrome |
| N gonorrhoeae Clinical Disseminated disease - | purulent arthritis, pustular rash on extremities; pharyngitis, neonatal conjunctivitis |
| N gonorrhoeae Diagnosis Lab Diagnostics | Gram stain for males. Thayer martin for females |
| N gonorrhoeae Treatment, Prevention, Control – | Ceftriaxone |
| N. meningitidis Organism structure morphology | Gram negative diplococci, oxidase +, catalase + Glucose and maltose fermentation |
| N. meningitidis Epidemiology | Reservoir of nasopharynx of healthy adults; leading cause of bacterial meningitis; C5-9 deficiencies at high risk; living in close proximity; inhalation of respiratory droplets |
| N. meningitidis Pathogenesis & Virulence Factors | Capsule, IgA protease, LOS and tissue damage |
| N. meningitidis Clinical Disease | 90% caused by A, B, C, Y, and W135 serotypes. Meningitis, small skin petechial rash, septicemia, Waterhouse-Friderichsen syndrome (hemorrhage into adrenal- disseminated intravascular coagulation), arthritis, pneumonia |
| N. meningitidis Diagnosis | Lab Diagnostics - agglutination test, chocolate and modified Thayer martin |
| N. meningitidis Treatment, Prevention, Control | penicillin; rifampin or Cipro for family members; vaccine - MPSV4 (all major serotypes but B); Bexsero for serotype B |
| Moraxella catarrhalis Organism structure morphology | Gram negative, oxidase positive, strict aerobic, diplococci |
| Moraxella catarrhalis Epidemiology - | Lower respiratory disease in adults (elderly) |
| Moraxella catarrhalis Clinical Disease - | Otitis media, sinusitis (children), RTI in elderly |
| Moraxella catarrhalis Treatment, Prevention, Control | Amoxicillin-clavulanate or Sulfamethoxazole and trimethoprim |
| Moraxella catarrhalis Third most common cause of | otitis media and sinusitis in children (after S. pneumoniae and H. influenzae) |
| Moraxella catarrhalis Lower respiratory disease in | adults (elderly) with COPD |
| Moraxella catarrhalis Resistant to | 1st-generation β-lactams, susceptible to everything else |
| Haemophilus influenzae B Organism structure morphology | Gram negative, pleiomorphic, facultative anaerobe, coccobacilli |
| Haemophilus influenzae B Epidemiology | Major cause of respiratory tract illness in unvaccinated |
| Haemophilus influenzae B Pathogenesis & Virulence Factors | Capsule, invasive, IgA protease, biofilm formation, avoid phagocytosis, LOS causes tissue damage |
| Haemophilus influenzae B Clinical Disease | Bacteremia and meningitis - Initial respiratory infection, spread from nasopharynx, Epiglottitis - children, cellulitis on cheeks or periorbital |
| Haemophilus influenzae B Diagnosis Lab Diagnostics | Gram negative rods in CSF, sputum; agglutination test, requires factors V (NAD) and X (Hemin) - chocolate agar, supplement factors in agar, and satellite test on blood agar |
| Haemophilus influenzae B Treatment, Prevention, Control | Ceftriaxone; 50% resistant to cillins; conjugate vaccine (non-typeable, use amox+clav or macrolides) |
| Bordetella pertussis Organism structure morphology | Gram negative, obligate aerobe, coccobacilli |
| Bordetella pertussis Epidemiology | Direct contact via respiratory droplets or fomites |
| Bordetella pertussis Pathogenesis & Virulence Factors - | Adherence to ciliated cells. Tracheal cytotoxin inhibits DNA synthesis, Adenylyl cyclase toxin directly increases cAMP, Pertussis toxin (AB5) ADP-ribosylates Gαi to increase cAMP |
| Bordetella pertussis Clinical Disease - | Sever cough, weight loss, seizures, hemorrhage |
| Bordetella pertussis Diagnosis | Lab Diagnostics - Regan-Lowe agar or Charcoal cephalexin blood agar |
| Bordetella pertussis Treatment, Prevention, Control | - Macrolides and Trimethoprim-sulfamethoxazole; vaccine - CTaP (acellular pertussis - pertussis toxoid and FHA (filamentous hemagglutinin) |
| Legonella pneumophillia Organism structure morphology | Gram negative, facultative intracellular rod, motile |
| Legonella pneumophillia Epidemiology - | Inhalation of aerosolized contaminated water (heat, stasis, and ,aerosolization) - can survive in cold and heat |
| Legonella pneumophillia Pathogenesis & Virulence Factors | Flagella, pili, T4SS to modify the phagosome |
| Legonella pneumophillia Clinical Disease | Pneumonia, very high fever moth-eaten lung tissue, Popcorn X-ray |
| Legonella pneumophillia Diagnosis | Lab Diagnostics - BCYE (buffered charcoal yeast extract) agar plus cysteine and iron; ELISA detects LPS in urine |
| Legonella pneumophillia Treatment, Prevention, Control - | Macrolides and fluoroquinolones |
| Mycoplama Organism structure and morphology | Facultative anaerobe, non-motile, pleiomorphic; no peptidoglycan, no cell wall, cholesterol in membrane |
| Mycoplama Epidemiology | community acquired by respiratory droplets |
| Mycoplama Pathogenesis & Virulence Factors | No invasion of epithelium, but attaches using a tip-like organelle, superantigen production (fibromyalgia, chronic fatigue, Gulf War Syndrome, RA) |
| Mycoplama Clinical Disease | Chronic carriage with no fever but dry coughing (walking pneumonia) |
| Mycoplama Diagnosis | Lab Diagnostics - Cold agglutinins (anti-RBC antibodies); Fried egg colony on Eaton's agar |
| Treatment, Prevention, Control | Macrolides |
| EPEC Epidemiology | Pediatric disease, Children <2 y.o., Small Intestine |
| EPEC Symptoms | Watery diarrhea, no fever or inflamation |
| EPEC Virulence Factors | Pedestal formation, A |
| EPEC Pathogenesis | Actin Rearrangement, M Cell Adherent, Disruption of microvilli structure-> malabsorption and diarrhea |
| EHEC STEC Epidemiology | Outbreaks (processed meat and vegetables), Large Intestine |
| EHEC STEC Symptoms | Hemorrhagic colitis, bloody diarrhea, Little or no fever, HUS |
| EHEC STEC Virulence factors | Pedestal formation, A |
| EHEC or STEC Pathogenesis | O157:H7, Disruption of microvilli structure-> malabsorption and diarrhea. Protein synthesis inhibited |
| EIEC Epidemiology | Food borne – Rare, Large Intestine |
| EIEC Symptoms | Severe inflammation, Fever, Mucus, blood, and PMNs |
| EIEC Virulence factors | Invasion plasmid, T3SS - actin rearrangement, Membrane ruffling |
| EIEC Pathogenesis | Formation of actin jet trail, Destruction of epithelial cells |
| ETEC Epidemiology | Travelers diarrhea, Small Intestine |
| ETEC Symptoms | Cholera-like, watery, No Fever or inflammation |
| ETEC Virulence factors | Colonization factors (CF), STa - cGMP increase, LT - cAMP increase |
| ETEC Pathogenesis | Impedes phagocytosis, Hyper secretion of fluids |
| EAEC Epidemiology | Travelers and infants in developing countries, Large |
| EAEC Symptoms | No Fever or inflammation watery Mucoid diarrhea Growth retardation |
| EAEC Virulence factors | Aggregative adherence fimbria (AAF) EAEC heat-stable enterotoxin (like STa) Plasmid encoded toxin (pet) |
| EAEC Pathogenesis | Staked bricks with shortening of microvilli, Exfoliation, Hyper secretion of fluids |